Page 558 - Enfeksiyon Hastalıkları Kitabı
P. 558
538 Enfeksiyon Hastalıkları
Öztürk R. Akut ishal. Türkiyede Sık Karşılaşılan Hastalıklar I dosages for complicated skin and skin structure infections in
(Yazarlar; Hamuryudan V, Öztürk R). İÜ Cerrahpaşa Tıp hospitalized patients, Clin Th er 2004;26:704–714.
Fakültesi Sürekli Tıp Eğitimi Etkinlikleri Sempozyum Dizisi, Ragnarsdottir B, Samuelsson M, Gustafsson MC, et al. Reduced
İstanbul; 2007.
toll-like receptor 4 expression in children with asymptoma-
Öztürk R. Clostridium diffi cile: Yeni ve yeniden gündeme gelen tic bacteriuria. J Infect Dis 2007; 196:475-484.
enfeksiyonlar (Yazarlar; Arman D, Ünal S). Bilimsel Tıp Ya- Raz R. Fosfomycin: an old—new antibiotic. Clin Microbiol In-
yınevi, Ankara; 2009.
fect 2012; 18: 4–7.
Öztürk R. Hastane enfeksiyonları: Hastane Enfeksiyonları: Ko- Reboli AC, Rotstein C, Pappas PG, et al: Anidulafungin ver-
runma ve Kontrol. (Yazarlar; Öztürk R, Saltoğlu N, Aygün sus fluconazole for invasive candidiasis. N Engl J Med
G). 1. baskı. Aksu Basım Yayın, İstanbu; 2008.
2007;356:2472-2482.
Öztürk R. İshal. İshal (Yazar; Öztürk R).. İstanbul Bulaşıcı Hastalık- Recep Öztürk. “Enfeksiyon Hastalıklarında Değişen Epidemiyo-
larla Savaş Derneği, İstanbul; 1998.
loji”. II. Türkiye Zoonotik Hastalıklar Sempozyumu (Açılış
Panel on Antiretroviral Guidelines Adults and Adolescents. Konferansı), 27-28 Kasım 2008, Ankara.
Guidelines for the Use of AntiretroviralAgents in HIV-1- Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S at al. A
Infected Adults and Adolescents. http://www. aidsinfo. nih. major epidemic of Chikungunya virus infection on Reu-
gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. nion island, France, 2005-2006. Am. J. Trop. Med. Hyg.
March 27, 2012:1-139. 2007;77(4):727-731.
Park H, Copeland C, Henry S, Barbul A. Complex wounds and their Replogle ML, Fleming DW, Cieslak PR. Emergence of antimic-
management. Surg Clin North Am 2010; 90(6): 1181-1194. robial-resistant shigellosis in Oregon. Clin Infect Dis 2000;
Parvizi J, Zmistowski B, Berbari EF, et al. New defi nition for 30: 515-9.
periprosthetic joint infection: from the Workgroup of the Reynolds JH, McDonald G, Alton H, Gordon SB. Pneumonia in
Musculoskeletal Infection Society. Clin Orthop Relat Res the immunocompetent patient.Br J Radiol. 2010;83(996):998-
2011;469:2992-2994. 1009.
Peacock JE, McGinnis MR, Cohen MS: Persistent neutrophilic Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy
meningitis. Medicine 1984;63:379–395. in the treatment of severe sepsis and septic shock. N Engl J
Med 2001; 345:1368.
Pelucchi C, Grigoryan L, Galeone C et al. Guideline fort he ma-
nagement of acute sore throat. Clin Microbiol Infect. 2012; Robbins GK, De Gruttola V, shafer RW, et al. Comparision of
18 (suppl 1): 1-27 sequential three-drug regimens as initial therapy for HIV-1
infection. N Engl J Med. 2003;349:2293-2303.
Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikungun-
ya, an epidemic arbovirosis. Lancet Infect Dis 2007;7:319-327. Roberts MC. Tetracycline therapy:update. Clin Infect Dis.
2003;36(4):462-467.
Pickering LK, Baker CJ, Freed GL, et al. Immunization programs
for infants, children, adolescents, and adults: clinical practi- Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult
ce guidelines by the Infectious Diseases Society of America. D. Recommendations for treatment of human infections ca-
Clin Infect Dis 2009; 49:817. used by Bartonella species. Antimicrob Agents Chemother.
2004 ;48(6):1921-1933.
Polat E, Turhan V, Aslan M, Müsellim B, Onem Y, Ertuğrul B.
First report of three culture confirmed human lyme cases in Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal teta-
Turkey. Mikrobiyol Bul.2010; 44:133-139. nus. Lancet. 2007 Dec 8;370(9603):1947-1959.
Popovic M, Steinort D, Pillai S, Joukhadar C. Fosfomycin: an Ross JJ, Hu LT. Septic arthritis of the pubic symphysis: review of
old, new friend? Eur J Clin Microbiol Infect Dis 2010; 29: 100 cases. Medicine (Baltimore) 2003;82(5):340-345.
127–142.
Ross JJ, Saltzman CL, Carling P, et al. Pneumococcal septic art-
Popp RL. Echocardiography. N Engl J Med 1990;323:165. hritis: review of 190 cases. Clin Infect Dis 2003;36:319-327.
Poutsiaka DD, Davidson LE, Kahn KL, et al. Risk factors for de- Ross JJ, Shamsuddin H. sternoclavicular septic arthritis: review
ath after sepsis in patients immunosuppressed before the of 180 cases. Medicine (Baltimore) 2004; 83 (3):139-148.
onset of sepsis. Scand J Infect Dis 2009; 41:469.
Rutala WA and DJ Weber. An overview of disinfection and ste-
Pratt DS. Liver chemistry and function tests. In: Sleisenger and rilization in health care facilities. In: Disin fection, Sterilizati-
Fordtran’s Gastro intestinal and Liver Diseases Pathophisio- on, and Antisepsis: Principles, Practices, Current Issues and
logy. (Eds; Feldman M, Fri edman LS, Brandt LJ). 9th., Pa: New Research (Eds; Rutala WA). Association for Profes-
Saunders Elsevier, Phile delphia; 2010. sionals in Infection Control and Epidemiology, Washington,
DC; 2007.
Prevention CfDCa. Preliminary FoodNet data on the incidence
of infection with pathogens transmitted commonly through Rutala WA and DJ Weber. Clinical effectiveness of low-
food-10 states, 2007. MMWR. 2008; 57: 366-370. temperature sterilization technology. Infect. Control Hosp.
Epidemiol. 1998;19:798-804.
Pritt BS, Clark CG. Amebiasis. Mayo Clin Proc. 2008;
83(10):1154-9;1159-1160. Rutala WA, Weber DJ.New disinfection and sterilization met-
hods. Emerg Infect Dis. 2001;7(2):348-53.
Pullukçu H. Gebelik ve toksoplazma enfeksiyonları. Gebelik ve
İnfeksiyonlar (Yazarlar; Taşova Y, Arman D). Baskıda, 2013. Sabina Y, Rahman A, Ray RC, Montet D. Yersinia enterocoliti-
ca: Mode of transmission, molecular insights of virulence,
R.G. Postier, S.L. Green and S.R. Klein et al., A multicenter, ran- and pathogenesis of infection. Journal of Pathogens 2011;
domized, open-label safety and efficacy study of tigecycline doi:10.4061/2011/429069.

